Skip to main content
SpringerLink
Log in

Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The authors investigate the role of extent of resection (EOR) and genetic markers on patient outcome and survival for LGGs. We conducted a retrospective cohort between 2005 and 2015, of 109 adult patients who underwent surgery for a LGG by a single surgeon. Volumetric computations of MRI studies were conducted to evaluate the EOR, and genetic markers (IDH1, 1p/19q co-deletion, and p53) were assessed and their effects on survival and neurological outcome were evaluated. The median EOR was 88.1%. Permanent postoperative neurological deficits were seen in 4.6% of patients. EOR was a significant predictor for both overall survival (OS) (hazard ratio [HR] = 0.979, 95% CI 0.961–0.980, p = 0.029) and progression free survival (PFS) (HR = 0.982, 95% CI 0.968–0.997, p = 0.018). Malignant progression free survival (MPFS) was predicted by the 1p/19q co-deletion (HR = 0.148, 95% CI 0.019–1.148, p = 0.048). Patients with EOR of 100% had a significantly better OS than EOR less than 90% (p = 0.038). Patients with an EOR of at least 76% had a better OS than EOR less than 76% (p = 0.025). Patients with an EOR of at least 71% had a better PFS than EOR less than 71% (p = 0.030). Preoperative tumor volume was found to have significant association with EOR (R2 = 0.049, p = 0.031). Increased EOR is associated with improved OS and PFS survival outcomes, while 1p/19q co-deletion provides improved MPFS. Understanding both surgical resections and molecular markers of the tumor are important for effective management of LGG patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Roelz R, Strohmaier D, Jabbarli R, Kraeutle R, Egger K, Coenen VA, Weyerbrock A, Reinacher PC (2016) Residual tumor volume as best outcome predictor in low grade glioma—a nine-years near-randomized survey of surgery vs. biopsy. Sci Rep 6:32286. doi:10.1038/srep32286

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Duffau H, Taillandier L (2015) New concepts in the management of diffuse low-grade glioma: proposal of a multistage and individualized therapeutic approach. Neurooncol 17:332–342. doi:10.1093/neuonc/nou153

    Google Scholar 

  3. Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frenay M, Grisold W, Grant R, Graus F, Hoang-Xuan K et al (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol 17:1124–1133. doi:10.1111/j.1468-1331.2010.03151.x

    Article  CAS  PubMed  Google Scholar 

  4. Jakola AS, Myrmel KS, Kloster R, Torp SH, Lindal S, Unsgard G, Solheim O (2012) Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA 308:1881–1888

    Article  CAS  PubMed  Google Scholar 

  5. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338–1345. doi:10.1200/JCO.2007.13.9337

    Article  PubMed  Google Scholar 

  6. Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, Talos F, Jolesz FA, Black PM (2005) Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 103:1227–1233. doi:10.1002/cncr.20867

    Article  PubMed  Google Scholar 

  7. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C (1998) Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 64:581–587

    Article  PubMed  PubMed Central  Google Scholar 

  8. Nakamura M, Konishi N, Tsunoda S, Nakase H, Tsuzuki T, Aoki H, Sakitani H, Inui T, Sakaki T (2000) Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults. Int Soc Cell 58:108–116

    CAS  Google Scholar 

  9. Philippon JH, Clemenceau SH, Fauchon FH, Foncin JF (1993) Supratentorial low-grade astrocytomas in adults. Neurosurgery 32:554–559

    Article  CAS  PubMed  Google Scholar 

  10. Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, MacDonald D, Cairncross G (1997) Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 15:1294–1301

    Article  CAS  PubMed  Google Scholar 

  11. Shaw E, Arusell R, Scheithauer B, O’Fallon J, O’Neill B, Dinapoli R, Nelson D, Earle J, Jones C, Cascino T et al (2002) Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20:2267–2276

    Article  CAS  PubMed  Google Scholar 

  12. Yeh SA, Ho JT, Lui CC, Huang YJ, Hsiung CY, Huang EY (2005) Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas. Br J Radiol 78:230–235. doi:10.1259/bjr/28534346

    Article  PubMed  Google Scholar 

  13. Sanai N, Berger MS (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753–764. doi:10.1227/01.neu.0000318159.21731

    Article  PubMed  Google Scholar 

  14. Schomas DA, Laack NN, Rao RD, Meyer FB, Shaw EG, O’Neill BP, Giannini C, Brown PD (2009) Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro-oncol 11:437–445. doi:10.1215/15228517-2008-102

    Article  PubMed  PubMed Central  Google Scholar 

  15. McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinones-Hinojosa A (2008) Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 63:700-707. doi:10.1227/01.NEU.0000325729.41085.73 author reply 707-8.

    Google Scholar 

  16. Ius T, Isola M, Budai R, Pauletto G, Tomasino B, Fadiga L, Skrap M (2012) Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article. J Neurosurg 117:1039–1052. doi:10.3171/2012.8.JNS12393

    Article  PubMed  Google Scholar 

  17. Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498. doi:10.1056/NEJMoa1402121

    Article  Google Scholar 

  18. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225; (discussion 226–229)

    Article  PubMed  Google Scholar 

  19. Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, Raza SM, Pascual-Gallego M, Ibrahim A, Hernandez-Hermann M, Gomez L, Ye X, Weingart JD et al (2014) Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neurooncol 16:113–122. doi:10.1093/neuonc/not137

    Google Scholar 

  20. Chaichana KL, Jusue-Torres I, Lemos AM, Gokaslan A, Cabrera-Aldana EE, Ashary A, Olivi A, Quinones-Hinojosa A (2014) The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors? J Neurooncol 120:625–634. doi:10.1007/s11060-014-1597-9

    Article  PubMed  PubMed Central  Google Scholar 

  21. Eseonu CI, Rincon-Torroella J, ReFaey K, Quinones-Hinojosa A (Accepted August 2016) The cost of brain surgery: awake versus asleep craniotomy for perirolandic region tumors. Neurosurgery

  22. Eseonu CI, Rincon-Torroella J, ReFaey K, Lee YM, Nangiana J, Vivas-Buitrago T, Quinones-Hinojosa A (Accepted September 2016) Awake craniotomy versus craniotomy under general anesthesia for perirolandic gliomas: evaluating perioperative complications and extent of resection. Neurosurgery

  23. Suzuki H, Aoki K, Chiba K, Sato Y, Shiozawa Y, Shiraishi Y, Shimamura T, Niida A, Motomura K, Ohka F et al (2015) Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47:458–468. doi:10.1038/ng.3273

    Article  CAS  PubMed  Google Scholar 

  24. Duffau H, Capelle L (2004) Preferential brain locations of low-grade gliomas. Cancer 100:2622–2626. doi:10.1002/cncr.20297

    Article  PubMed  Google Scholar 

  25. Gousias K, Schramm J, Simon M (2014) Extent of resection and survival in supratentorial infiltrative low-grade gliomas: analysis of and adjustment for treatment bias. Acta Neurochir 156:327–337. doi:10.1007/s00701-013-1945-0

    Article  PubMed  Google Scholar 

  26. Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, Storm-Mathisen I, Hirschberg H (1997) Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 15:3129–3140

    Article  CAS  PubMed  Google Scholar 

  27. Nicolato A, Gerosa MA, Fina P, Iuzzolino P, Giorgiutti F, Bricolo A (1995) Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients. Surg Neurol 44:208–221; discussion 221-223.

    Article  CAS  PubMed  Google Scholar 

  28. Scerrati M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF (1996) Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. J Neurol Neurosurg Psychiatry 61:291–296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Mariani L, Siegenthaler P, Guzman R, Friedrich D, Fathi AR, Ozdoba C, Weis J, Ballinari P, Seiler RW (2004) The impact of tumour volume and surgery on the outcome of adults with supratentorial WHO grade II astrocytomas and oligoastrocytomas. Acta Neurochir 146:441–448. doi:10.1007/s00701-004-0222-7

    Article  CAS  PubMed  Google Scholar 

  30. Daniels TB, Brown PD, Felten SJ, Wu W, Buckner JC, Arusell RM, Curran WJ, Abrams RA, Schiff D, Shaw EG (2011) Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys 81:218–224. doi:10.1016/j.ijrobp.2010.05.003

    Article  PubMed  PubMed Central  Google Scholar 

  31. Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, Afra D, Cornu P, Bolla M, Vecht C et al (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076–2084

    Article  PubMed  Google Scholar 

  32. Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard JL, Bauchet L, Pallud J, Peruzzi P, Baron MH, Kujas M et al (2013) Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article. J Neurosurg 118:1157–1168. doi:10.3171/2013.1.JNS121

    Article  PubMed  Google Scholar 

  33. Sorensen AG, Patel S, Harmath C, Bridges S, Synnott J, Sievers A, Yoon YH, Lee EJ, Yang MC, Lewis RF et al (2001) Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol 19:551–557

    Article  CAS  PubMed  Google Scholar 

  34. Janny P, Cure H, Mohr M, Heldt N, Kwiatkowski F, Lemaire JJ, Plagne R, Rozan R (1994) Low grade supratentorial astrocytomas. Management and prognostic factors. Cancer 73:1937–1945

    Article  CAS  PubMed  Google Scholar 

  35. Frazier JL, Johnson MW, Burger PC, Weingart JD, Quinones-Hinojosa A (2010) Rapid malignant transformation of low-grade astrocytomas: report of 2 cases and review of the literature. World Neurosurg 73:53–62. doi:10.1016/j.surneu.2009.05.010 discussion e5.

    Article  PubMed  Google Scholar 

  36. Recht LD, Lew R, Smith TW (1992) Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 31:431–436. doi:10.1002/ana.410310413

    Article  CAS  PubMed  Google Scholar 

  37. Piepmeier J, Christopher S, Spencer D, Byrne T, Kim J, Knisel JP, Lacy J, Tsukerman L, Makuch R (1996) Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 38:872–878 (discussion 878–879)

    Article  CAS  PubMed  Google Scholar 

  38. Jiao Y, Killela PJ, Reitman ZJ, Rasheed AB, Heaphy CM, de Wilde RF, Rodriguez FJ, Rosemberg S, Oba-Shinjo SM, Nagahashi Marie SK et al (2012) Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget 3:709–722

    Article  PubMed  PubMed Central  Google Scholar 

  39. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–1812. doi:10.1126/science.1164382

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773. doi:10.1056/NEJMoa0808710

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. van den Bent MJ, Brandes AA, Taphoorn MJ, Kros JM, Kouwenhoven MC, Delattre JY, Bernsen HJ, Frenay M, Tijssen CC, Grisold W et al (2013) Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31:344–350. doi:10.1200/JCO.2012.43.2229

    Article  PubMed  Google Scholar 

  42. Cairncross G, Wang M, Shaw E, Jenkins R, Brachman D, Buckner J, Fink K, Souhami L, Laperriere N, Curran W et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31:337–343. doi:10.1200/JCO.2012.43.2674

    Article  CAS  PubMed  Google Scholar 

  43. Juratli TA, Kirsch M, Robel K, Soucek S, Geiger K, von Kummer R, Schackert G, Krex D (2012) IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas. J Neurooncol 108:403–410. doi:10.1007/s11060-012-0844-1

    Article  CAS  PubMed  Google Scholar 

  44. Mariani L, Deiana G, Vassella E, Fathi AR, Murtin C, Arnold M, Vajtai I, Weis J, Siegenthaler P, Schobesberger M et al (2006) Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy. J Clin Oncol 24:4758–4763

    Article  CAS  PubMed  Google Scholar 

  45. Nahed BV, Redjal N, Brat DJ, Chi AS, Oh K, Batchelor TT, Ryken TC, Kalkanis SN, Olson JJ (2015) Management of patients with recurrence of diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline. J Neurooncol 125:609–630. doi:10.1007/s11060-015-1910-2

    Article  CAS  PubMed  Google Scholar 

  46. Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R et al (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27:5874–5880. doi:10.1200/JCO.2009.23.6497

    Article  CAS  PubMed  Google Scholar 

  47. Leu S, von Felten S, Frank S, Boulay JL, Mariani L (2016) IDH mutation is associated with higher risk of malignant transformation in low-grade glioma. J Neurooncol 127:363–372. doi:10.1007/s11060-015-2048-y

    Article  CAS  PubMed  Google Scholar 

  48. Berger MS, Deliganis AV, Dobbins J, Keles GE (1994) The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74:1784–1791

    Article  CAS  PubMed  Google Scholar 

  49. Kreth FW, Faist M, Rossner R, Volk B, Ostertag CB (1997) Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. A new pattern of prognostic factors. Cancer 79:370–379. doi:10.1002/(SICI)1097-0142(19970115)79:23.0.CO;2-X

    Article  CAS  PubMed  Google Scholar 

  50. Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, Barbaro NM, Parsa AT, Berger MS, McDermott MM (2008) Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg 109:817–824. doi:10.3171/JNS/2008/109/11/0817

    Article  PubMed  Google Scholar 

  51. Hervey-Jumper SL, Berger MS (2014) Role of surgical resection in low- and high-grade gliomas. Curr Treat Options Neurol 16:1–19. doi:10.1007/s11940-014-0284-7

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Surgery and Oncology Outcomes Lab, Johns Hopkins University, Baltimore, MD, USA

    Chikezie I. Eseonu, Francisco Eguia, Karim ReFaey, Oscar Garcia, Kaisorn Chaichana & Alfredo Quinones-Hinojosa

  2. Department of Pathology, Johns Hopkins University, Baltimore, MD, USA

    Fausto J. Rodriguez

  3. Brain Tumor Stem Cell Laboratory, Department of Neurologic Surgery, Mayo Clinic, Florida, 4500 San Pablo Rd. S, Jacksonville, FL, 32224, USA

    Alfredo Quinones-Hinojosa

Authors
  1. Chikezie I. Eseonu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francisco Eguia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karim ReFaey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oscar Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fausto J. Rodriguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kaisorn Chaichana
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alfredo Quinones-Hinojosa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alfredo Quinones-Hinojosa.

Ethics declarations

Conflict of interest

There are no conflict of interests to report or financial disclosures related to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eseonu, C.I., Eguia, F., ReFaey, K. et al. Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival. J Neurooncol 134, 65–74 (2017). https://doi.org/10.1007/s11060-017-2486-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-017-2486-9

Keywords

Search

Navigation